Skip to main content
. 2010 Jan 15;15(1):37–50. doi: 10.1634/theoncologist.2009-0117

Table 2.

Comparing principles underlying the use of combined cytotoxic agents versus combining targeted agents

graphic file with name onc00110-0528-t02.jpg

Abbreviations: CML, chronic myelogenous leukemia; MTA, molecularly targeted agent; PD, pharmacodynamic; PK, pharmacokinetic.

Adapted from Takimoto CH, Calvo E. Chapter 3: Principles of oncologic pharmacotherapy. In: Pazdur R, Coia L, Hoskins WJ et al., eds. Cancer Management: A Multidisciplinary Approach, Ninth Edition. Lawrence, KS: CMP Healthcare Media LLC, 2005:23–42.